DCX Systems Ltd

BSE: 543650

10

total announcements

543650.BO · 15 min delayed

BSECompany Update▲ PositiveOrder Win17 Aug 2026

DCX Systems Ltd

Intimation of receipt of Purchase Orders.

DCX Systems Ltd has received purchase orders worth INR 15.19 Crores and INR 3.09 Crores from its customers and wholly-owned subsidiary, respectively, in the normal course of business.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion13 Aug 2026

DCX Systems Ltd

Updates on signing of Memorandum of Understanding (MOU).

DCX Systems Ltd has signed a non-binding Memorandum of Understanding (MOU) with the Government of Tamil Nadu to expand the scope of its proposed operations in the state. The expanded scope will cover Electronic Intelligence (ELINT), Communications Intelligence (COMINT), and Communication Systems, in addition to the baseline project scope of setting up a state-of-the-art facility for the design, development, manufacturing, and supply of Airborne Maritime Radar Systems, Fire Control Radar Systems, Counter Drone Systems, and other Radar and Electronic Warfare Systems.

Read more →📎 1 attachment
BSECompany Update12 Aug 2026

DCX Systems Ltd

Statement of Deviation & Variation as on June 30, 2026.

DCX Systems Ltd has filed a statement of deviation and variation in the utilization of funds raised through its Initial Public Offer (IPO) and Qualified Institutional Placement (QIP) as on June 30, 2026, stating that there is no deviation or variation in the use of proceeds from the objects stated in the prospectus and placement document.

Read more →📎 1 attachment
BSECompany UpdateResults12 Aug 2026

DCX Systems Ltd

Monitoring Agency Report for the quarter ended June 30, 2026.

DCX Systems Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations, detailing the utilization of proceeds from its Initial Public Offering (IPO) and Qualified Institutional Placement (QIP). The report indicates that there was a change in the amount within the objects specified in the offer document, which required shareholder approval. The purpose of investment in its subsidiary Renal Advanced System Private Limited (RASPL) has been revised to loan repayment as against capital expenditure.

Read more →📎 1 attachment